Table 1 Demographics and baseline characteristics of the patients
progression (−) | progression (+) | p value | |
|---|---|---|---|
(n = 21) | (n = 7) | ||
Men, n (%) | 18 (86) | 6 (86) | >0.99 |
Age, y | 59 ± 14 | 63 ± 13 | 0.50 |
Laboratory parameters, (mg/dl) | |||
ANP | 38 ± 42 | 65 ± 23 | 0.11 |
BNP | 77 ± 172 | 139 ± 136 | 0.40 |
D-dimer | 0.63 ± 0.40 | 1.65 ± 2.05 | 0.56 |
C-reactive protein | 1.06 ± 2.07 | 1.98 ± 4.94 | 0.93 |
Clinical history, n (%) | |||
Hypertension | 11 (52) | 4 (57) | >0.99 |
Diabetes mellitus type 2 | 7 (33) | 3 (43) | 0.67 |
Current smoker | 3 (14) | 1 (14) | >0.99 |
Dyslipidemia | 8 (38) | 1 (14) | 0.37 |
Medication, n (%) | |||
Statins | 3 (14) | 0 (0) | 0.55 |
Antiarrhythmic medication | 3 (14) | 1 (14) | >0.99 |
Calcium channel blockers | 6 (29) | 1 (14) | 0.64 |
ß-blockers | 6 (29) | 1 (14) | 0.64 |
ACE inhibitors or ARBs | 8 (38) | 3 (43) | >0.99 |